vs
合众银行（FSBC）与IRONWOOD PHARMACEUTICALS INC（IRWD）财务数据对比。点击上方公司名可切换其他公司
IRONWOOD PHARMACEUTICALS INC的季度营收约是合众银行的1.1倍（$47.7M vs $45.1M），合众银行净利率更高（41.3% vs -4.8%，领先46.1%），过去两年合众银行的营收复合增速更高（21.3% vs -20.2%）
合众银行是总部设在美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行。它旗下核心运营实体为美国银行全国协会，以US Bank品牌开展业务，提供银行、投资、抵押等金融服务。
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
FSBC vs IRWD — 直观对比
营收规模更大
IRWD
是对方的1.1倍
$45.1M
净利率更高
FSBC
高出46.1%
-4.8%
两年增速更快
FSBC
近两年复合增速
-20.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $47.7M |
| 净利润 | $18.6M | $-2.3M |
| 毛利率 | — | — |
| 营业利润率 | — | 14.3% |
| 净利率 | 41.3% | -4.8% |
| 营收同比 | — | -47.3% |
| 净利润同比 | 42.0% | -200.9% |
| 每股收益（稀释后） | $0.87 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSBCIRWD
| Q1 26 | $45.1M | — | ||
| Q4 25 | $43.5M | $47.7M | ||
| Q3 25 | $41.3M | $122.1M | ||
| Q2 25 | $38.3M | $85.2M | ||
| Q1 25 | $35.3M | $41.1M | ||
| Q4 24 | $35.2M | $90.5M | ||
| Q3 24 | $31.8M | $91.6M | ||
| Q2 24 | $30.7M | $94.4M |
净利润FSBCIRWD
| Q1 26 | $18.6M | — | ||
| Q4 25 | $17.6M | $-2.3M | ||
| Q3 25 | $16.3M | $40.1M | ||
| Q2 25 | $14.5M | $23.6M | ||
| Q1 25 | $13.1M | $-37.4M | ||
| Q4 24 | $13.3M | $2.3M | ||
| Q3 24 | $10.9M | $3.6M | ||
| Q2 24 | $10.8M | $-860.0K |
营业利润率FSBCIRWD
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | 14.3% | ||
| Q3 25 | 53.8% | 61.8% | ||
| Q2 25 | 52.4% | 53.2% | ||
| Q1 25 | 52.0% | -70.7% | ||
| Q4 24 | 55.1% | 34.8% | ||
| Q3 24 | 48.0% | 28.0% | ||
| Q2 24 | 49.4% | 26.5% |
净利率FSBCIRWD
| Q1 26 | 41.3% | — | ||
| Q4 25 | 40.6% | -4.8% | ||
| Q3 25 | 39.6% | 32.8% | ||
| Q2 25 | 37.9% | 27.7% | ||
| Q1 25 | 37.1% | -90.9% | ||
| Q4 24 | 37.9% | 2.5% | ||
| Q3 24 | 34.4% | 4.0% | ||
| Q2 24 | 35.2% | -0.9% |
每股收益（稀释后）FSBCIRWD
| Q1 26 | $0.87 | — | ||
| Q4 25 | $0.83 | $0.01 | ||
| Q3 25 | $0.77 | $0.23 | ||
| Q2 25 | $0.68 | $0.14 | ||
| Q1 25 | $0.62 | $-0.23 | ||
| Q4 24 | $0.61 | $0.03 | ||
| Q3 24 | $0.52 | $0.02 | ||
| Q2 24 | $0.51 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $644.4M | $215.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $458.5M | $-261.8M |
| 总资产 | $5.0B | $396.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FSBCIRWD
| Q1 26 | $644.4M | — | ||
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M |
总债务FSBCIRWD
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M |
股东权益FSBCIRWD
| Q1 26 | $458.5M | — | ||
| Q4 25 | $445.8M | $-261.8M | ||
| Q3 25 | $431.3M | $-264.2M | ||
| Q2 25 | $416.7M | $-308.2M | ||
| Q1 25 | $406.5M | $-334.1M | ||
| Q4 24 | $396.6M | $-301.3M | ||
| Q3 24 | $389.9M | $-311.3M | ||
| Q2 24 | $380.5M | $-321.7M |
总资产FSBCIRWD
| Q1 26 | $5.0B | — | ||
| Q4 25 | $4.8B | $396.9M | ||
| Q3 25 | $4.6B | $396.1M | ||
| Q2 25 | $4.4B | $342.9M | ||
| Q1 25 | $4.2B | $327.2M | ||
| Q4 24 | $4.1B | $350.9M | ||
| Q3 24 | $3.9B | $389.5M | ||
| Q2 24 | $3.6B | $395.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $74.6M |
| 自由现金流经营现金流 - 资本支出 | — | $74.6M |
| 自由现金流率自由现金流/营收 | — | 156.3% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $127.0M |
8季度趋势，按日历期对齐
经营现金流FSBCIRWD
| Q1 26 | — | — | ||
| Q4 25 | $72.6M | $74.6M | ||
| Q3 25 | $18.8M | $47.6M | ||
| Q2 25 | $17.8M | $-15.1M | ||
| Q1 25 | $15.5M | $20.0M | ||
| Q4 24 | $51.8M | $15.2M | ||
| Q3 24 | $17.5M | $9.9M | ||
| Q2 24 | $16.0M | $33.5M |
自由现金流FSBCIRWD
| Q1 26 | — | — | ||
| Q4 25 | $71.4M | $74.6M | ||
| Q3 25 | $18.6M | $47.6M | ||
| Q2 25 | $17.5M | $-15.1M | ||
| Q1 25 | $15.4M | $19.9M | ||
| Q4 24 | $51.2M | — | ||
| Q3 24 | $17.3M | $9.9M | ||
| Q2 24 | $15.8M | $33.4M |
自由现金流率FSBCIRWD
| Q1 26 | — | — | ||
| Q4 25 | 164.3% | 156.3% | ||
| Q3 25 | 45.0% | 39.0% | ||
| Q2 25 | 45.8% | -17.7% | ||
| Q1 25 | 43.5% | 48.4% | ||
| Q4 24 | 145.5% | — | ||
| Q3 24 | 54.5% | 10.8% | ||
| Q2 24 | 51.6% | 35.4% |
资本支出强度FSBCIRWD
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | 0.0% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 1.8% | 0.0% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.7% | 0.1% |
现金转化率FSBCIRWD
| Q1 26 | — | — | ||
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.15× | 1.19× | ||
| Q2 25 | 1.23× | -0.64× | ||
| Q1 25 | 1.18× | — | ||
| Q4 24 | 3.89× | 6.74× | ||
| Q3 24 | 1.60× | 2.71× | ||
| Q2 24 | 1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSBC
| Net Interest Income | $43.5M | 96% |
| Noninterest Income | $1.6M | 4% |
IRWD
暂无分部数据
